Follistatin 344 Supplier China: COA Buyer Guide

Lock the Follistatin 344 identity and isoform

Use Follistatin 344 and FST-344 as controlled synonyms only after confirming the exact amino-acid construct or molecular reference. Distinguish it from other Follistatin forms, fragments and unrelated products that share an FST abbreviation. State the production route, form, target composition or purity criteria, 1mg nominal content, quantity and RUO status. Require the same identity and lot across the quote, specification, COA, analytical files, label and packing list before the offer enters price comparison.

Map the production and release chain

Ask whether the material is produced by recombinant expression, synthesis or another documented route and identify the manufacturing, purification, testing, filling and release sites. The route does not by itself prove quality, but it determines relevant process controls and analytical interpretation. Document the legal seller, batch owner, release authority, inventory owner and shipper. Confirm who investigates deviations, retains original batch records and controls changes to cell system, process, site, method or critical materials where applicable.

Match analytical methods to a protein-oriented material

Request identity, purity or composition and quantity evidence appropriate to the exact FST-344 material and production route. HPLC and mass spectrometry may be part of the package, but the supplier should explain method suitability, sample preparation, expected result and limitations. Review sample identifier, profiles or chromatograms, specifications, results, dates and approval. Avoid a checklist that equates one HPLC percentage with correct isoform identity, intact structure, quantity and every other quality attribute.

Verify the 1mg content claim

Ask how the nominal 1mg is assigned, what tolerance applies and whether it refers to net target material or total lyophilized mass. Obtain appropriate quantitative results or controlled filling and reconciliation records. If formulation components are present, require enough information to interpret the amount without requesting unsupported proprietary detail. Keep identity, purity or composition, concentration and fill quantity separate. A per-vial price is not comparable until the quantity basis and evidence scope are aligned.

Control storage, shipment and receiving records

Obtain supplier-supported storage and transport conditions for the unopened research material, plus packaging configuration and an excursion-response process. Confirm released stock, MOQ, manufacturing and test lead time, document approval timing and shipping term. Reconcile product, unit, lot and quantity across COA, analytical attachments, SDS, label, invoice and packing list. At receipt, record package and any monitor condition, preserve lot traceability and quarantine unexplained temperature, seal, label or quantity deviations.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• FST 344 1mg
• IGF-1 LR3 Supplier Guide
• Third-Party Testing Guide

Frequently asked questions